Search results
Results From The WOW.Com Content Network
The more important question is: Why have Inovio's shares fallen for several weeks now?
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
Investors are not impressed with the biotech's latest plan to raise cash.
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
The stock was down -8.49% to trade at $857.81 per share in the afternoon session as of 1:16 p.m. ET. 12:54 p.m. ET: Stocks lose steam after strong morning gains Here were the main moves in markets ...
The stock of Inovio Pharmaceuticals (NAS:INO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.
Inovio Pharmaceuticals (INO) disappoints with earnings and revenue miss in the second quarter. Shares depreciate in after-hours trading. Inovio (INO) Q2 Earnings & Revenues Fall Shy of Estimates